Dare Bioscience, Inc. Earnings Per Share (Basic)
Dare Bioscience, Inc. (DARE) reported Earnings Per Share (Basic) of -$0.20 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- Dare Bioscience, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.20.
- Dare Bioscience, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.21.
- Dare Bioscience, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.28.
- Dare Bioscience, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$0.45, a 129.41% decline year-over-year.
- Dare Bioscience, Inc. earnings per share, basic for fiscal 2025 was -$1.20.
- Dare Bioscience, Inc. earnings per share, basic for fiscal 2024 was -$0.48.
- Dare Bioscience, Inc. earnings per share, basic for fiscal 2023 was -$4.15.
- Dare Bioscience, Inc. earnings per share, basic for fiscal 2022 was -$0.37.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.20 10-Q · filed 2026-08-13 | -$0.41 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | -$0.21 10-Q · filed 2026-05-14 | |||||||
| 2025-12-31 | -$1.20 10-K · filed 2026-03-26 | |||||||
| 2025-09-30 | -$0.28 10-Q · filed 2025-11-13 | -$1.18 10-Q · filed 2025-11-13 | ||||||
| 2025-06-30 | -$0.45 10-Q · filed 2026-08-13 | -$0.95 10-Q · filed 2026-08-13 | ||||||
| 2025-03-31 | -$0.50 10-Q · filed 2026-05-14 | |||||||
| 2024-12-31 | -$0.48 10-K · filed 2026-03-26 | |||||||
| 2024-09-30 | -$0.55 10-Q · filed 2025-11-13 | $0.17 10-Q · filed 2025-11-13 | ||||||
| 2024-06-30 | $1.53 10-Q · filed 2025-08-14 | $0.73 10-Q · filed 2025-08-14 | ||||||
| 2024-03-31 | -$0.81 10-Q · filed 2025-05-13 | -$0.07 10-Q · filed 2024-05-14 | ||||||
| 2023-12-31 | -$0.69 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$1.79 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$4.15 10-K · filed 2025-03-31 | -$0.35 10-K · filed 2024-03-28 | ||||
| 2023-09-30 | -$1.09 10-Q · filed 2024-11-14 | -$0.09 10-Q · filed 2023-11-09 | -$3.45 10-Q · filed 2024-11-14 | -$0.29 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | -$1.22 10-Q · filed 2024-08-12 | -$0.10 10-Q · filed 2023-08-10 | -$2.32 10-Q · filed 2024-08-12 | -$0.19 10-Q · filed 2023-08-10 | ||||
| 2023-03-31 | -$0.09 10-Q · filed 2024-05-14 | -$0.29 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$0.37 derived: net income ÷ weighted average shares · filed 2024-05-14 | |||||
| 2022-12-31 | -$0.20 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$0.28 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$0.37 10-K · filed 2024-03-28 | |||||
| 2022-09-30 | -$0.08 10-Q · filed 2023-11-09 | -$0.18 10-Q · filed 2023-11-09 | ||||||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-10 | -$0.10 10-Q · filed 2023-08-10 | ||||||
| 2022-03-31 | -$0.10 10-Q · filed 2023-05-11 | -$0.26 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$0.44 derived: net income ÷ weighted average shares · filed 2023-05-11 | |||||
| 2021-12-31 | -$0.18 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.36 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.63 10-K · filed 2023-03-30 | |||||
| 2021-09-30 | -$0.18 10-Q · filed 2022-11-10 | -$0.45 10-Q · filed 2022-11-10 | ||||||
| 2021-06-30 | -$0.18 10-Q · filed 2022-08-09 | -$0.35 10-Q · filed 2022-08-09 | ||||||
| 2021-03-31 | -$0.16 10-Q · filed 2022-05-12 | |||||||
| 2020-12-31 | -$0.22 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$0.46 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$0.72 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$0.91 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | -$0.24 10-Q · filed 2021-11-10 | -$0.50 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$0.69 10-Q · filed 2021-11-10 | |||||
| 2020-06-30 | -$0.27 10-Q · filed 2021-08-12 | -$0.45 10-Q · filed 2021-08-12 | ||||||
| 2018-06-30 | -$0.31 derived: net income ÷ weighted average shares · filed 2019-08-14 | -$1.12 derived: net income ÷ weighted average shares · filed 2019-08-14 | ||||||
| 2016-12-31 | -$47.07 derived: net income ÷ weighted average shares · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |